Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$105.0 - $178.37 $133,875 - $227,421
-1,275 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$125.11 - $180.0 $455,025 - $654,660
-3,637 Reduced 74.04%
1,275 $226,000
Q1 2021

May 06, 2021

BUY
$126.27 - $191.71 $259,484 - $393,964
2,055 Added 71.93%
4,912 $655,000
Q4 2020

Feb 09, 2021

BUY
$81.94 - $135.34 $234,102 - $386,666
2,857 New
2,857 $387,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.48B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.